Assessing transmission blockade in plasmodium spp.

Methods in Molecular Biology

Volumn 923, Issue , 2013, Pages 577-600

  Blagborough, Andrew M ^a   Delves, Michael J ^a   Ramakrishnan, Chandra ^a   Lal, Kalpana ^a   Butcher, Geoffrey ^a   Sinden, Robert E ^a  

^a NONE

Author keywords

Berghei; Blockade; Culture; Drug; Exflagellation; Falciparum; Gametocyte; Mosquito; Oocyst; Ookinete; Passage; Plasmodium; Sexual; Sporozoite; Transmission; Vaccine

Indexed keywords

4 AMINOBENZOIC ACID; ANESTHETIC AGENT; FRUCTOSE; HEPARIN; MERBROMIN; PHENYLHYDRAZINE; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA MODIFICATION; FEEDING; FREEZING; GAMETOCYTE; GENE VECTOR; GIEMSA STAIN; HOST; MEMBRANE; MOSQUITO; MOUSE; NONHUMAN; OOCYST; PARASITE EXAMINATION; PARASITEMIA; PLASMODIUM; PLASMODIUM (LIFE CYCLE STAGE); PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; PURIFICATION; RETICULOCYTOSIS; RODENT; SPOROZOITE; VERTEBRATE;

EID: 84934440194     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-26-7_40     Document Type: Article

References (29)

1. Sinden RE (2010) A biologist's perspective on malaria vaccine development. Hum Vaccin 6:3-11
2. Rosenberg R (2008) Malaria: Some considerations regarding parasite productivity. Trends Parasitol 24:487-491
3. Butcher GA (1997) Antimalarial drugs and the mosquito transmission of Plasmodium. Int J Parasitol 27:975-987
4. Sauerwein RW (2007) Malaria transmissionblocking vaccines: The bonus of effective malaria control. Microbes Infect 9:792-795
5. Carter R (2001) Transmission blocking malaria vaccines. Vaccine 19:2309-2314
6. Malkin EM et al (2005) Phase I clinical trial of Pvs25H: A transmission blocking vaccine for Plasmodium vivax malaria. Vaccine 23: 3131-3138
7. Stowers A, Carter R (2001) Current developments in malaria transmission-blocking vaccines. Expert Opin Biol Ther 1:619-628
8. Wu Y et al (2008) Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. PLoS One 3:e2636
9. LeBlanc R et al (2008) Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation. Vaccine 26:185-192
10. Lobo CA et al (1999) Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies. Infect Immun 67:1688-1693
11. Blagborough AM et al (2010) Intranasal and intramuscular immunization with Baculovirus Dual Expression System-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission. Vaccine 28:6014-6020
12. Miyata T et al (2011) Adenovirus-vectored Plasmodium vivax ookinete surface protein, Pvs25, as a potential transmission-blocking vaccine. Vaccine 29:2720-2726
13. Franke-Fayard B et al (2004) A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol Biochem Parasitol 137:23-33
14. Janse CJ et al (2006) High efficiency transfection of Plasmodium berghei facilitates novel selection procedures. Mol Biochem Parasitol 145:60-70
15. Ramjanee S et al (2007) The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials. Vaccine 25:886-894
16. Mlambo G et al (2008) Murine model for assessment of Plasmodium falciparum transmissionblocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25. Infect Immun 76:2018-2024
17. Delves MJ, Sinden RE (2010) A semi-automated method for counting fluorescent malaria oocysts increases the throughput of transmission blocking studies. Malar J 29:9-35
18. Sinden RE et al (2007) Progression of Plasmodium berghei through Anopheles stephensi is density-dependent. PLoS Pathog 3:e195
19. Vaid A, Sharma P (2006) PfPKB, a protein kinase B-like enzyme from Plasmodium falciparum : II. Identification of calcium/calmodulin as its upstream activator and dissection of a novel signalling pathway. J Biol Chem 281:27126-27133
20. Winger LA et al (1988) Ookinete antigens of Plasmodium berghei. Appearance on the zygote surface of an Mr 21 kDa determinant identified by transmission-blocking monoclonal antibodies. Parasite Immunol 10:193-207
21. Ponnudurai T et al (1986) Synchronization of Plasmodium falciparum gametocytes using an automated suspension culture system. Parasitology 93:263-274
22. Graves PM et al (1984) Gametocyte production in cloned lines of Plasmodium falciparum. Am J Trop Med Hyg 33:1045-1050
23. Ifediba T, Vanderburg JP (1981) Complete in vitro maturation of Plasmodium falciparum gametocytes. Nature 294:364-366
24. Read M, Hyde JE (1993) Simple in vitro cultivation of the malaria parasite Plasmodium falciparum (erythrocytic stages) suitable for large-scale preparations. Methods Mol Biol 21:43-55
25. Brown KN, Hills LA (1981) Erythrocyte destruction and protective immunity to malaria: Enhancement of the immune response by phenylhydrazine treatment. Tropenmed Parasitol 32:67-72
26. van den Berghe L (1954) The history of the discovery of Plasmodium berghei. Indian J Malariol 8:241-243
27. Vincke IH (1954) Natural history of Plasmodium berghei. Indian J Malariol 8:245-256
28. Yoeli M (1965) Studies on Plasmodium berghei in nature and under experimental conditions. Trans R Soc Trop Med Hyg 59:255-276
29. Bray RS (1954) The mosquito transmission of Plasmodium berghei. Indian J Malariol 8: 263-274